Journal of Pharmacology and Experimental Therapeutics: 372 (2)

February 01, 2020; Volume 372,Issue 2

Cardiovascular

You have access
Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins
Maria V. Fawaz, Sang Yeop Kim, Dan Li, Ran Ming, Ziyun Xia, Karl Olsen, Irina D. Pogozheva, John J.G. Tesmer and Anna Schwendeman

Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 193-204; DOI: https://doi.org/10.1124/jpet.119.257568

You have access
M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate
Rían W. Manville, Maria Papanikolaou and Geoffrey W. Abbott

Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 148-156; DOI: https://doi.org/10.1124/jpet.119.263350

You have access
OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention
David R. Maguire, Lisa R. Gerak, Gerta Cami-Kobeci, Stephen M. Husbands, Charles P. France, Barbara Belli and Peter Flynn

Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 205-215; DOI: https://doi.org/10.1124/jpet.119.261511
You have access
5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury
Epiphani C. Simmons, Natalie E. Scholpa, Kristan H. Cleveland and Rick G. Schnellmann

Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 216-223; DOI: https://doi.org/10.1124/jpet.119.262410
Open Access
A Novel G Protein–Biased Agonist at the δ Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain
Alexandra E. Conibear, Junaid Asghar, Rob Hill, Graeme Henderson, Eva Borbely, Valeria Tekus, Zsuzsanna Helyes, Josephine Palandri, Chris Bailey, Ingemar Starke, Bengt von Mentzer, David Kendall and Eamonn Kelly

Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 224-236; DOI: https://doi.org/10.1124/jpet.119.258640

You have access
DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats
Sota Kato, Teisuke Takahashi, Noriyuki Miyata and Richard J. Roman

Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 166-174; DOI: https://doi.org/10.1124/jpet.119.262782

You have access
EP2/4 Receptors Promote the Synthesis of PGE₂ Increasing Tissue Damage in Bovine Endometrial Explants Induced by Escherichia coli
Chao Zhang, Lingrui Wang, Tingting Li, Wei Mao, Bo Liu and Jinshan Cao

Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 175-184; DOI: https://doi.org/10.1124/jpet.119.262444
Open Access
All-Trans Retinoic Acid Inhibits Migration and Invasiveness of Rheumatoid Fibroblast-Like Synoviocytes
Nerea Mosquera, Angela Rodriguez-Trillo, Francisco J. Blanco, Antonio Mera-Varela, Antonio Gonzalez and Carmen Conde

Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 185-192; DOI: https://doi.org/10.1124/jpet.119.261370

You have access
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein
Yunden Jinsmaa, Risa Isonaka, Yehonatan Sharabi and David S. Goldstein

Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 157-165; DOI: https://doi.org/10.1124/jpet.119.262246